.png&w=384&q=75)
We are a top-performing early-stage impact venture capital fund
2021
Triple Impact Capital is an early-stage VC firm that believes that founders addressing the most pressing challenges of today, will build the most valuable companies of tomorrow. The firm invests in three main areas, all of which are being transformed by AI: Healthtech, Sustainable Innovation and Economic Opportunity. The firm's principals have invested in a combined 150 startup companies from the seed stage and have a track record of picking unicorn category winners. They respectively spun out of the most active early-stage venture fund in New York City and a publicly-traded investment firm. To date, the firm has exhibited a track record of success: 1. Fund I performance: Ranked in the top 5% of venture firms in its 2021 vintage year for TVPI and IRR 2. Two exits: First completed in Q4 2024 with proceeds distributed to LPs. Second was a stock transaction. Since forming the fund, they have executed over 50 transactions 3. Portfolio Momentum: Exciting pre-seed investments include companies like Camber (behavioral health SaaS, Series B led by Andreessen), Bandana (hourly worker job platform, Series Seed led by General Catalyst) and Berry Street Health (tele-dietician platform, Series B led by Northzone) 4. Pre-Fund I performance: On-thesis portfolio includes 2 unicorns and is marked at a 9.3x multiple on invested capital 5. Top Tier Co-Investors: Invested prior to and alongside leading global VC funds, such as Andreessen Horowitz, General Catalyst, Founder Collective, and Khosla (early backers of companies such as Facebook, Airbnb, and Uber) Based on the success of Fund I, the firm is now executing the same strategy with their Fund II. They have already completed their first Fund II close and made their first two investments, both of which have already been marked up - with one company accelerating from zero to $15M in annualized revenue in just over a year.
